The polymorphisms of the TNF-α gene in multiple sclerosis?- A meta-analysis

Molecular Biology Reports

Volumn 38, Issue 6, 2011, Pages 4137-4144

  Xu, Lidan ^a   Yuan, Weiguang ^a   Sun, Haiming ^a   Zhang, Xuelong ^a   Jia, Xueyuan ^a   Shen, Chao ^a   Zhao, Yanling ^a   Sun, Donglin ^a   Yu, Yang ^a   Jin, Yan ^a   Fu, Songbin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Multiple sclerosis; Polymorphism; TNF

Indexed keywords

ARTICLE; ASIAN; CAUCASIAN; CLINICAL FEATURE; DISEASE PREDISPOSITION; ETHNICITY; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HUMAN; MULTIPLE SCLEROSIS; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TNF ALPHA GENE;

ADULT; FEMALE; GENETIC HETEROGENEITY; HUMANS; MALE; MODELS, GENETIC; MULTIPLE SCLEROSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052462500     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0533-0     Document Type: Article

References (38)

1. Ramagopalan SV, DeLuca GC, Degenhardt A, Ebers GC (2008) The genetics of clinical outcome in multiple sclerosis. J Neuroimmunol 201:183-199. doi:10.1016/j.jneuroim.2008.02.016.
2. Losonczi E, Bencsik K, Nagy ZF, Honti V, Szalczer E, Rajda C, Illes Z, Matyas K, Rozsa C, Csepany T et al (2009) Tumour necrosis factor alpha gene (TNF-alpha)-376 polymorphism in Hungarian patients with primary progressive multiple sclerosis. J Neuroimmunol 208:115-118. doi:10.1016/j.jneuroim.2009.01. 004.
3. Duvefelt K, Anderson M, Fogdell-Hahn A, Hillert J (2004) A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens 63:13-20. (Pubitemid 38130437)
4. Losonczi E, Bencsik K, Nagy ZF, Honti V, Szalczer E, Rajda C, Illes Z, Matyas K, Rozsa C, Csepany T et al (2009) Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis. J Neuroimmunol 208:115-118. doi:S0165-5728(09)00017-4.
5. Drulovic J, Popadic D, Mesaros S, Dujmovic I, Cvetkovic I, Miljkovic D, Stojsavljevic N, Pravica V, Pekmezovic T, Bogdanovic G et al (2003) Decreased frequency of the tumor necrosis factor alpha -308 allele in Serbian patients with multiple sclerosis. Eur Neurol 50:25-29. doi:10.1159/000070855. (Pubitemid 36736966)
6. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P (1996) Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett 215:75-78. doi:S0304394096129207. (Pubitemid 26313221)
7. Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG (1997) A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology 49:626-628. (Pubitemid 27368919)
8. Lucotte G, Bathelier C, Mercier G (2000) TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients. Mult Scler 6:78-80. (Pubitemid 30218899)
9. Maurer M, Kruse N, Giess R, Kyriallis K, Toyka KV, Rieckmann P (1999) Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients. J Neurol 246:949-954. doi:92460949.415. (Pubitemid 29512168)
10. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826. (Pubitemid 27465551)
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560. doi: 10.1136/bmj.327.7414.557. (Pubitemid 37088507)
12. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. doi:10.1002/sim.1186. (Pubitemid 34746062)
13. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
14. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
15. Munafo MR, Clark TG, Flint J (2004) Assessing publication bias in genetic association studies: evidence from a recent metaanalysis. Psychiatry Res 129:39-44. (Pubitemid 39574435)
16. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
17. Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L, Figueredo MA, de la Concha EG (1999) Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 53:1361-1363. (Pubitemid 29480107)
18. Huizinga TWJ, Westendorp RGJ, Bollen E, Keijsers V, Brinkman BMN, Langermans JAM, Breedveld FC, Verweij CL, vande Gaer L, Dams L et al (1997) TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72:149-153. (Pubitemid 27062770)
19. Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS (1997) Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology 49:378-385. (Pubitemid 27368870)
20. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P (1996) Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett 215:75-78. (Pubitemid 26313221)
21. Drulovic J, Popadic D, Mesaros S, Dujmovic I, Cvetkovic I, Miljkovic D, Stojsavljevic N, Pravica V, Pekmezovic T, Bogdanovic G et al (2003) Decreased frequency of the tumor necrosis factor alpha-308 allele in Serbian patients with multiple sclerosis. Eur Neurol 50:25-29. doi:10.1159/000070855. (Pubitemid 36736966)
22. Forte GI, Ragonese P, Salemi G, Scola L, Candore G, D'Amelio M, Crivello A, Di Benedetto N, Nuzzo D, Giacalone A et al (2006) Search for genetic factors associated with susceptibility to multiple sclerosis. Ann N Y Acad Sci 1067:264-269. doi: 1067/1/264. (Pubitemid 43806333)
23. He B, Navikas V, Lundahl J, Soderstrom M, Hillert J (1995) Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol 63:143-147. (Pubitemid 26020718)
24. Maurer M, Kruse N, Giess R, Kyriallis K, Toyka KV, Rieckmann P (1999) Gene polymorphism at position-308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients. J Neurol 246:949-954. (Pubitemid 29512168)
25. Mihailova S, Ivanova M, Mihaylova A, Quin L, Mikova O, Naumova E (2005) Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J Neuroimmunol 168:138-143. doi:S0165-5728(05) 00268-7. (Pubitemid 41396411)
26. Mycko M, Kowalski W, Kwinkowski M, Buenafe AC, Szymanska B, Tronczynska E, Plucienniczak A, Selmaj K (1998) Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J Neuroimmunol 84:198-206. (Pubitemid 28248406)
27. Ristic S, Lovrecic L, Starcevic-Cizmarevic N, Brajenovic-Milic B, Jazbec SS, Sepcic J, Kapovic M, Peterlin B (2007) Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Eur Neurol 57:203-207. doi:10.1159/000099159. (Pubitemid 46701476)
28. Sotgiu S, Pugliatti M, Serra C, Rosati G, Dolei A, Marrosu MG (1999) Tumor necrosis factor 2 allele does not contribute to increased tumor necrosis factor-alpha production in Sardinian multiple sclerosis. Ann Neurol 46:799-800. (Pubitemid 29518146)
29. Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG (1997) A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology 49:626-628. (Pubitemid 27368919)
30. Zipp F, Weber F, Huber S, Sotgiu S, Czlonkowska A, Holler E, Albert E, Weiss EH, Wekerle H, Hohlfeld R (1995) Geneticcontrol of multiple-sclerosis- increased production of lymphotoxin and tumor-necrosis-factor-alpha by HLA-DR2(+) T-cells. Ann Neurol 38:723-730.
31. Dong YX, Xu ZR, Lin PY (2006) Association among serous and cerebrospinal fluid TNF-alpha level, gene polymorphisms of TNF-alpha and multiple sclerosis in Han nationality of southern China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:677-679. doi: 940623163.
32. Kamali-Sarvestani E, Nikseresht A, Aflaki E, Sarvari J, Gharesi-Fard B (2007) TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis. Acta Neurol Scand 115:161-166. doi:10.1111/j.1600-0404.2006. 00743.x. (Pubitemid 46219208)
33. Sarial S, Shokrgozar MA, Amirzargar A, Shokri F, Radfar J, Zohrevand P, Arjang Z, Sahraian MA, Lotfi J (2008) IL-1, IL-1R and TNF alpha gene polymorphisms in Iranian patients with multiple sclerosis. Iran J Allergy Asthma Immunol 7:37-40. (Pubitemid 351534732)
34. Weinshenker BG, Hebrink DD, Atkinson E, Kantarci OH (2001) Association of a tumor necrosis factor alpha polymorphism with MS susceptibility. Neurology 57:1341-1342. (Pubitemid 32947406)
35. Kauffman MA, Moron DG, Sandoval G, Sica RE, Garcea O, Villa AM (2007) Is tumor necrosis factor-376a promoter polymorphism associated with susceptibility to multiple sclerosis? Medicina-Buenos Aires 67:436-438. (Pubitemid 350081397)
36. Sharief MK, Hentges R (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325:467-472.
37. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. PNAS 94:3195-3199. (Pubitemid 27157287)
38. Hajeer AH, Hutchinson IV (2001) Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 62:1191-1199. (Pubitemid 33032271)